Abbott Laboratories

Abbott shares sag as diagnostic, nutrition biz sales decline

Abbott saw its shares down 10% at the end of trading Thursday as the market digested weaknesses from its fourth-quarter and full-year earnings report.

Ben Adams Jan 23, 2026 8:05am

Abbott Lingo smartphone reading at breakfast

Walmart to sell Abbott's CGM in US 1st

Oct 21, 2025 12:40pm

FDA shores up executive team with 2 hires—Chutes & Ladders

Jul 1, 2022 9:30am

Abbott launches 1st study of its dual-chamber leadless pacemaker

Feb 7, 2022 11:47am

Abbott weathers COVID testing fluctuations with $7.7B in sales

Jan 26, 2022 11:23am

Abbott nabs FDA clearance for its EnSite heart mapping platform

Jan 12, 2022 9:00am